Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell envelope anionic polymers are essential negatively charged components of the bacterial cell wall, primarily comprising teichoic acids (wall teichoic acids and lipoteichoic acids) in Gram-positive bacteria and lipopolysaccharides in Gram-negative bacteria (Brown et al., 2013, Nature Reviews Microbiology). These polymers play critical roles in maintaining cell wall integrity, regulating ion homeostasis by sequestering divalent cations like magnesium, and modulating the activity of autolytic enzymes (Swoboda et al., 2010, Chembiochem). In the context of pathogenesis, they serve as key virulence factors by facilitating adhesion to host tissues and evading the host immune system through the modulation of surface charge (Raetz and Whitfield, 2002, Annual Review of Biochemistry). Because of their high negative charge density, they are the primary targets for cationic antimicrobial peptides (AMPs) and certain lipopeptide antibiotics like daptomycin and polymyxins (Straus and Hancock, 2006, Biochimica et Biophysica Acta). Targeting these polymers or their biosynthetic pathways represents a significant strategy for developing new antibacterial agents to combat multi-drug resistant infections, although bacteria can develop resistance by modifying these polymers to reduce their negative charge (Trimble et al., 2016, Cold Spring Harbor Perspectives in Medicine).
Cationic drugs and peptides bind to the anionic polymers via electrostatic attraction, which facilitates their insertion into the lipid bilayer or interference with cell wall assembly, ultimately leading to membrane depolarization or lysis (Straus and Hancock, 2006, Biochimica et Biophysica Acta; Trimble et al., 2016, Cold Spring Harbor Perspectives in Medicine).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell envelope anionic polymers.